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Summary--In this work we have probed the mechanism responsible for two non-DNA-bind- 
ing states of the mouse glucoeorticoid receptor. In the first case, transformed receptors were 
treated with hydrogen peroxide. It is known that oxidizing agents promote the formation of 
disulfide bonds in the glucocorticoid receptor, but it has not been determined what domains 
are involved in any disulfide bond formation that leads to inactivation of DNA-binding 
activity. We show here that hydrogen peroxide inhibits DNA-binding by the 15-kDa tryptic 
fragment containing the DNA-binding fingers with the same concentration dependency as it 
inhibits DNA-binding by the uncleaved receptor. This suggests that all of the effect of peroxide 
is on sulfhydryl groups within the zinc fingers. After dissociation (transformation) of cytosolic 
heteromeric glucocorticoid receptor complexes, only a portion (40--60%) of the dissociated 
receptors can bind to DNA-cellulose. We show that the 15-kDa tryptic fragment derived from 
the portion of transformed receptors that do not bind to DNA is itself competent at 
DNA-binding. 
INTRODUCTION 
We previously reported that hydrogen peroxide 
inhibits both transformation of glucocorticoid 
receptors to the DNA-binding state and DNA- 
binding by previously transformed receptors [1]. 
Silva and Cidlowski [2] have provided direct 
evidence that oxidizing agents promote the for- 
mation of intramolecular disulfide bonds in the 
glucocorticoid receptor, and inhibition of 
DNA-binding could result from such disulfide 
bond formation. A major question that has not 
yet been answered is whether disulfide bond 
formation occurs between the DNA-binding 
domain and another domain of the receptor or 
whether formation of disulfide bonds within the 
DNA-binding domain accounts for inhibition 
of DNA-binding activity. In this work, we show 
that hydrogen peroxide inhibits DNA-binding 
by the 15-kDa tryptic fragment of the receptor, 
suggesting that disulfide bond formation within 
the DNA-binding domain accounts for the 
effect. 
After transformation (activation) of the 
glucocorticoid receptor, two forms of the 
monomeric receptor can be distinguished by 
isoelectric focusing (pI ~ 5.7 and 6.0-6.5)[3]. 
The charge heterogeneity has been localized to 
a M~ 26,500 fragment corresponding to residues 
499--743 in the steroid-binding region of the 
human receptor, suggesting that some modifi- 
cation of the steroid-binding domain may regu- 
late the ability of the receptor to bind to 
DNA [4]. Consistent with this proposal, we 
show here that the 15-kDa tryptic fragment 
[residues 374-505 (mouse)] from the non-DNA- 
binding fraction of the transformed mouse glu- 
cocorticoid receptor has DNA-binding activity. 
EXPERIMENTAL 
Chemicals 
[6,7-3H]Triamcinolone acetonide (42.8Ci/ 
mmol), and ~251 conjugated goat anti-mouse and 
goat anti-rabbit IgG were obtained from New 
England Nuclear (Boston, MA). Radioinert 
dexamethasone, goat anti-mouse and anti- 
rabbit IgG-horseradish peroxidase conjugate, 
were from Sigma Chemical Company (St Louis, 
MO). The BuGR2 monoclonal antibody against 
the glucocorticoid receptor was kindly provided 
by Dr Robert W. Harrison. 
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Cell culture and fractionation 
L929 mouse fibroblasts were grown in mono- 
layer culture in Dulbecco's modified Eagle 
medium supplemented with 10% bovine or calf 
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serum. Cells were harvested in late log phase 
growth by scraping into Earle's balanced saline 
followed by a second wash and centrifugation at 
500g. The washed cells were resuspended in 
1.5 vol of HEPES buffer (10 mM HEPES, 1 mM 
EDTA, pH7.35 at 4°C) and ruptured by 
Dounce homogenization. Homogenates were 
centrifuged for 1 h at 100,000g. The super- 
natant from this centrifugation was removed 
and is referred to as "cytosol". 
DNA-binding assay 
Cytosol was bound overnight at 0°C with 
200 nM dexamethasone. To transform receptors 
to the DNA-binding state, cytosol containing 
steroid-bound receptors was incubated for I h at 
25°C. Incubations containing hydrogen per- 
oxide were prepared as indicated in the figure 
legends. For assay of DNA-binding, 100~tl 
aliquots of incubation mix were incubated for 
1 h at 4°C with a 200 #1 suspension of 12.5% 
DNA-cellulose. The pellets were washed 3 times 
with l ml of buffer and solubilized with SDS 
sample buffer and analyzed by SDS-PAGE as 
described below. 
Receptor partial proteolysis 
Cleavage of receptor was performed in whole 
cytosol after transformation and before other 
treatments essentially as described pre- 
viously[4]. Freshly prepared TPCK-treated 
trypsin (200/~g/ml final concentration) was 
added to cytosol and allowed to incubate on ice 
for 1 h. To stop proteolysis, 1 mg/ml soybean 
trypsin inhibitor was added for 30 min on ice. 
Immunoadsorption of receptor 
The BuGR anti-receptor antibody (hybri- 
doma culture supernatant) or non-immune 
mouse IgG (1 mg/ml) was preadsorbed to pro- 
tein A-Sepharose by rotation with the Sepha- 
rose beads for 2 h at 4°C and the beads were 
then washed 3 times with 1 ml aliquots of TEG 
buffer [10mM TES, 4raM EDTA, 10% (w/v) 
glycerol, 50 mM NaC1, pH 7.6]. Aliquots 
(100-400/~1) of cytosol were mixed with pread- 
sorbed antibody pellets, rotated for 1 h at 4°C, 
and the pellets were washed 3 times with 1 ml 
aliquots of TEG buffer. 
Gel electrophoresis and immunoblotting 
SDS-PAGE was performed in 7 or 10% slab 
gels essentially as described previously [4]. Gels 
were cooled to 4°C during electrophoresis. All 
samples were extracted from DNA-cellulose or 
protein A-Sepharose by boiling in SDS sample 
buffer with or without 10% fl-mercaptoethanol. 
M r standards were: myosin, Mr 205,000; fl- 
galactosidase, M r 116,000; phosphorylase B, Mr 
97,000; bovine serum albumen, Mr 66,000; egg 
albumen, Mr 45,000; glyceraldehyde-3-phos- 
phate dehydrogenase, Mr 36,000; carbonic an- 
hydrase, Mr 29,000; trypsinogen, M r 24,000; 
soybean trypsin inhibitor; M r 21,000, and ~t- 
l a c t a l b u m i n ,  M r 14,500. 
Immunoblotting was carried out by transfer- 
ring proteins from acrylamide slab gels to 
Immobilon-P membranes under transfer con- 
ditions of 2 h x 0.6 A for the intact receptor and 
16 h × 0.1 A for the 15-kDa tryptic receptor 
fragment. Immobilon-P membranes were then 
incubated with 1% BuGR antibody against the 
glucocorticoid receptor followed by a second 
incubation with ~25I-labeled goat anti-mouse 
IgG. 
RESULTS AND DISCUSSION 
To determine if hydrogen peroxide inhibits 
DNA-binding through a direct action on the 
DNA-binding domain, both intact and trypsin- 
cleaved receptors in L cell cytosol were treated 
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Fig. 1. Hydrogen peroxide is equally effective at inhibiting the DNA-cellulose binding activity of the 
uncleaved glucocorticoid receptor and the 15-kDa tryptic fragment of the receptor. Aliquots of cytosol 
(230/al) were transformed to the DNA-binding state and incubated (or not) with trypsin to cleave the 
glucocorticoid receptor. Samples were then incubated with increasing concentrations of hydrogen peroxide 
for 1 h at 0°C and bound to DNA-cellulose. After washing, the DNA-bound proteins in the cellulose 
pellets were solubilized in sample buffer, resolved on SDS-PAGE, transferred to Immobilon-P mem- 
branes, and blotted with BuGR anti-receptor antibody, followed by ~25I-labeled counterantibody and 
autoradiography. The concentration (mM) of peroxide is indicated above each lane. 
Transformed glucocorticoid receptor 
with various concentrations of the oxidizing 
agent for 1 h at 0°C. Receptors were then bound 
to DNA-cellulose and the amount of receptor or 
receptor fragment binding to DNA is shown in 
Fig. 1. It is clear that under these conditions 
where the receptor is in cytosol hydrogen per- 
oxide inhibits DNA-binding by the 15-kDa 
tryptic fragment with essentially the same con- 
centration dependency as it inhibits DNA-bind- 
ing by the intact receptor. In other experiments, 
we have shown that peroxide treatment does not 
lead to cleavage of receptor protein in cyto- 
sol [6]. The inhibition of DNA-binding activity 
caused by 20 mM hydrogen peroxide treatment 
of the 15-kDa fragment can be overcome by 
incubating samples for many hours at 0°C with 
30 mM dithiothreitol and 1 mM ZnCI 2 [7]. 
The 15-kDa tryptic fragment [8] of the gluco- 
corticoid receptor contains the two zinc 
"fingers" and the BuGR epitope [6]. This frag- 
ment contains 11 cysteines, of which 8 are 
involved in the tetrahedral coordination of zinc. 
One mechanism by which the oxidizing agent 
could inhibit DNA-binding is by promoting the 
formation of disulfide bridges between vicinal 
thiols, resulting in the elimination of zinc and 
disrupting the finger structure, which is required 
for receptor binding to DNA [9]. The fact that 
hydrogen peroxide inhibits DNA-binding by 
the 15-kDa fragment strongly suggests that 
disulfide bond formation between the DNA- 
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Fig. 2. The 15-kDa tryptic fragment derived from the 
non-DNA-binding fraction of the transformed glucocorti- 
cold receptor has DNA-binding activity. Cytosol containing 
dexamethasone-bound giucocorticoid receptors was incu- 
bated I h at 25°C to transform the receptors to the DNA- 
binding state. The cytosol was then extracted twice for 1 h 
at 4°C with DNA-cellulose to remove the DNA-binding 
fraction of receptor. Half of the DNA-cellulose-extracted 
cytosol was treated with trypsin to generate the 15-kDa 
tryptic fragment of the receptor. Uncleared and cleaved 
receptors were then bound again to DNA-cellulose. After 
centrifuging out the DNA-cellulose-bound receptors, the 
unbound receptor was extracted from the supernatant by 
adsorption to protein A-Sepharose using BuGR anti-recep- 
tor antibody. Receptor or fragment in the DNA-cellulose 
and immune pellets was then solubilized in sample buffer 
and resolved by SDS--PAGE and immunoblotting. Lane 1, 
the receptor in the supernatant after the second DNA-cellu- 
lose extraction. The sample of lane 1 was then incubated a 
third time with DNA-cellulose and separated into DNA- 
bound (lane 2) and non-DNA-bound (lane 3) fractions. 
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binding domain and another domain, such as 
the hormone-binding domain, does not account 
for redox inhibition of DNA-binding by the 
intact receptor. As an alternative to disulfide 
bond formation, it is possible that reversible 
oxidation products, such as sulfenic or sulfinic 
acids are formed, as has been proposed for 
redox regulation of Fos and Jun-binding to 
DNA [10]. 
In the experiment shown in Fig. 2, dexa- 
methasone-bound receptors in L cell cytosol 
were transformed by heating and then bound to 
DNA-cellulose. About half of the receptors 
bound to DNA-cellulose, and the non-DNA- 
binding receptors in the supernatant were ex- 
tracted a second time with DNA. Receptors that 
did not bind after two extractions with DNA- 
cellulose are shown in lane 1. The non-DNA- 
binding receptors were then cleaved with trypsin 
and incubated again with DNA-cellulose. As 
shown in lane 2 in the bottom half of Fig. 2, the 
15-kDa fragment derived from the non-DNA- 
binding intact receptor (compare with lanes 2 
and 3, top) binds to DNA. Thus, it would seem 
that the inability of this fraction of the trans- 
formed receptor to bind to DNA is not intrinsic 
to the DNA-binding fingers themselves. This 
leads us to propose that another domain (per- 
haps the hormone-binding domain as suggested 
by the data of Harmon et al. [4]) can block the 
DNA-binding domain in a portion of receptors 
after dissociation of the hsp90-containing recep- 
tor heterocomplex. 
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